Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination

Cited by (238)

Items 201–238 of 238

1. Covid‐19: Medical, Social and Psychological Aspects
   Zohar Lederman · 2021 · Wiley eBooks
2. A Novel CRISPR-Engineered, Stem Cell-Derived Cellular Vaccine
   Krishnendu Chakraborty, Abishek Chandrashekar, Adam Sidaway, Elizabeth Latta, Jingyou Yu, Katherine McMahan, Victoria M. Giffin, Cordelia Manickam, Kyle W. Kroll, Matthew Mosher et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
3. Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
   Silvina Raiden, Jorge Raul Geffner · 2021 · The Lancet Regional Health - Americas
4. Dose de rappel du vaccin COVID-19 : que savons-nous à ce jour ?
   Yousra Kherabi, Thibault Fiolet, Sacha Rozencwajg, Jean‐Philippe Salaün, Nathan Peiffer‐Smadja · 2022 · Anesthésie & Réanimation
5. Nuevos retos en el desarrollo y uso de vacunas contra la COVID-19.
   José Esparza, Alexis Hipólito García, Manuel E. Figuera, Flor Helene Pujol · 2022 · Salus
6. Long-term immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population. Secondary Study Based on a Randomized Clinical Trial
   Tian Yao, Xiaohong Zhang, Shengcai Mu, Yana Guo, Xiuyang Xu, Junfeng Huo, Zhiyun Wei, Ling Liu, Xiaoqing Li, Hong Li et al. · 2022 · medRxiv
7. Self-Reported Use of COVID-19 Immunologic Test Results to Inform Decisions About Daily Activities and COVID-19 Vaccination
   Miao Jiang, Nicholas K. Akers, Darcy B. Gill, Benjamin Eckhert, Emily Svejnoha, Harlan S. Robins · 2022 · medRxiv
8. PERSISTENT IMMUNITY AFTER MILD SARS CoV-2 INFECTION - THE CoNAN-LONG TERM STUDY -
   Clara Schnizer, Nico Andreas, Wolfgang Vivas, Thomas Kamradt, Michael Baier, Michael Kiehntopf, Stefan Glöckner, André Scherag, Bettina Löffler, Steffi Kolanos et al. · 2022 · medRxiv
9. Therapeutic Modalities for Coronavirus SARS-CoV-2 (COVID-19)
   2022 · Advances in Hematology and Oncology Research
10. Impacts of viral pathogenesis and vaccine immunization on the host humoral immune response in SARS-CoV-2 and associated variants of concern (VOCs) infection
    Sougata Roy Chowdhury, Subhendu Chakrabarty, Modhurima Chakraborti, Amlan Kumar Das · 2023 · Elsevier eBooks
11. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination
    Valeriya Pozdnyakova, Brittany Weber, Susan C. Cheng, Joseph E. Ebinger · 2023 · Heart Failure Clinics
12. Genetic-Based Vaccine Vectors
    David B. Weiner, Kathrin Ute Jansen, Tonya L. Villafana · 2023 · Elsevier eBooks
13. Whole blood immune memory cells is not sufficient to predict SARS-CoV-2 vaccine responsiveness
    Sujoy Khan, Kristina Emsell-Needham · 2023 · Indian Journal of Medical Microbiology
14. Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2
    Arezki Chekaoui, Mikhail Novikov, Zhiquan Xiang, Mohadeseh Hasanpourghadi, Robert Ambrose, Arezki Chekaoui, Dakota Newman, Wynetta Giles‐Davis, Xiang Zhou · 2023 · Research Square
15. IgG responses against SARS-CoV-2 vaccines AZD1222 and BBV-152 and breakthrough infections among health care workers in southern India
    Anusha Rohit, Caroline D’Souza, Suresh Kumar, Meenachi Ct, V Vinothini, Siva Perumal, M. Philip, Raju George, Iddya Karunasagar · 2024 · Heliyon
16. Comparative characteristics of the cellular immune response to SARS-CoV-2 during infection and post-vaccination
    Клюева Светлана Николаевна, Бугоркова Светлана Александровна, Кравцов Александр Леонидович, T. N. Kashtanova, Кожевников Виталий Александрович · 2023 · Medical Immunology (Russia)
17. Description of Clinical Outcomes of Janssen’s Ad26.COV2.S Prime and Single Boost for COVID-19 from January 2021 through July 2022 at a large Kentucky study site
    Trevor LC Hass, Paul S Schulz, Mark J. Dougherty, David F Dougherty, Richard Neil Greenberg · 2024 · Norton Healthcare Medical Journal
18. Overview of Infectious Diseases of Concern to Dental Practitioners: Airborne Pathogens
    Martina Majstorović, Glenn Canares · 2024 · Springer eBooks
19. Laboratory tests for diagnostics of cell immunity against SARS-CoV-2 (review of literature)
    P.I. Ivanova, A. V. Lobov, E. A. Pogodina, E.V. Sorokina, Irina Zh. Shubina · 2024 · Laboratory Service
20. SARS-CoV-2 spike protein in infectivity
    Alaa Muayad Altaie, Rania Hamdy, Mohamed Ibrahim Husseiny, Sameh S. M. Soliman · 2025 · Elsevier eBooks
21. Randomised Trial of a Single Dose of Ad26.COV2.S, BNT162b2 or SARS-CoV-2-rS-PN in Previously Vaccinated and Unvaccinated Adults Living with and without HIV in South Africa: Safety and Immunogenicity
    Vaneshree Govender, Tarylee Reddy, Pholo W. Maenetje, Trevor Beattie, Tania Adonis, Tanya Nielson, Jayajothi Moodley, John Mdluli, Aruna Bhoola, Stacey Angelo et al. · 2025 · SSRN Electronic Journal
22. Mesoporous Silicon Microparticles enhance robust immunity and protection against SARS-CoV-2 in mice and improves memory response in human PBMCs.
    Ana López-Gomez, Irene Real-Arévalo, Elsa Mayol, Jana Ausio Cendra, Diego Laxalde-Fernández, Pablo Nogales‐Altozano, Benigno Rivas-Pardo, Beatriz Amorós-Pérez, Beatriz Martín-Adrados, Ignacio Juárez et al. · 2025 · Research Square
23. Should fully immunized people wear masks indoors? An infectious disease physician weighs in
    Peter V Chin-Hong · 2021
24. Memory T Cell Responses
    Vandana Kalia, Rafi Ahmed, Surojit Sarkar · 2025 · Elsevier eBooks
25. Durability of neutralizing antibody and T-cell responses in COVID-19 patients after infection and booster vaccination
    Yao Lin, Xiaolin Jiang, Jun-Xia Cao, Qiang Guo, Mengna Wu, Shuzhi Wu, Li‐Jun Duan, Yuan Li Shen, Bingdong Zhan, Junfen Lin et al. · 2025 · Vaccine X
26. Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates
    Тухватулин Амир Ильдарович, Ilya V. Gordeychuk, Alina Sh. Dzharullaeva, Inna V. Dolzhikova, Баюрова Екатерина Олеговна, Fatima M. Izhaeva, Ковыршина Анна Витальевна, Житкевич Алла Сергеевна, Darya Avdoshina, Stanislav A. Gulyaev et al. · 2025 · Frontiers in Immunology
27. Impact of the bivalent COVID-19 booster on spike-specific t cell responses
    Amparo Martínez-Pérez, Rosa Isela Gálvez, Alba Grifoni, Alessandro Sette, Peter K. Gregersen, Daniela Weiskopf · 2025 · Vaccine
28. Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations
    Anass Abbad, Brian Lerman, Jordan Ehrenhaus, Diego Sebastian Ojeda, Charles Gleason, Gagandeep Singh, Zain Khalil, Ana Silvia Gonzalez-Reiche, Komal Srivastava, Ana Fernández-Sesma et al. · 2025 · Vaccine
29. Immunogenicity of COVID-19 Vaccines in the Upper Respiratory Tract: A Comparative Study of Pfizer-BioNTech and Johnson & Johnson Vaccines among Ugandan adults
    Victoria Menya Biribawa, Musema Kizito, HenryRoger Ssemunywa, Priscillah Mulungi, Alex Mukisa, Judith Norah Namatovu, Claire Biribawa, Duncan Kabiito, Mudarshiru Bbuye, Henry Kyobe Bosa et al. · 2025
30. Additional file 1 of Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint
    Chen, Xinhua, Wang, Wei, Chen, Xinghui, Wu, Qianhui, Sun, Ruijia, Shijia Ge, Zheng, Nan, Lu, Wanying, Yang, Juan, Lance Everett Rodewald et al. · 2022 · Figshare
31. Additional file 1 of Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection
    Wang, Fuzhen, Baoying Huang, Deng, Yao, Zhang, Shaobai, Liu, Xiaoqiang, Wang, Lei, Liu, Qianqian, Zhao, Li, Lin Tang, Wang, Wenling et al. · 2023 · Figshare
32. Associations between the microbiome and immune responses to an adenovirus-based HIV-1 candidate vaccine are distinct between African and US cohorts
    Yuhao Li, Daniel J Stieh, Lindsay Droit, Andrew HyoungJin Kim, Rachel Rodgers, Kathie A. Mihindukulasuriya, Leran Wang, Maria Grazia Pau, Olive Yuan, Herbert W. Virgin et al. · 2026 · mSystems
33. Rapid and potent induction of protective mucosal immunity against SARS-CoV-2 by an adenovirus-vectored nanoparticle vaccine
    Shixiong Li, Qiong Zi, Junhao Fan, Guangzhen Jiang, Yao Zhang, Danni Feng, Zumrat Nur, Xiaoqing Liu, Jintao Lai, Tao Chen et al. · 2026 · Journal of Nanobiotechnology
34. Dynamics of Antibody Responses to COVID-19 Vaccination in Senegalese Adults: A Multicentre Longitudinal Study
    Flore Biscotine N. Makoutchouang, Nalda Debsikréo, N'da Kouamé Nazaire Kouadio, Isaac Darko Otchere, Ndèye Dieynaba Diouf, Abdoulaye Leye SARR, M Guèye, Joséphine Khady Badiane, Ousmane Diouf, Aminata Mboup et al. · 2026 · Open Journal of Immunology
35. Low seroprevalence of neutralizing antibodies to gorilla adenovirus 32 (GRAd32) in southern African populations supports evaluation of this vector platform for HIV vaccine development
    Nonhlanhla N. Mkhize, Anna patjane, Nomcebo Shusha, Ashleigh Welsh, Tandile Hermanus, Prudence Kgagudi, Thopisang P. Motlou, Linda‐Gail Bekker, Glenda Gray, Nigel Garrett et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
36. Early innate immune signatures correlate with Ad26.COV2.S vaccine immunogenicity and protective efficacy
    Alessandro Colarusso, Kathryn E. Stephenson, Ai-ris Yonekura Collier, Frank Wegmann, Roland C. Zahn, Malika Aïd, Dan H. Barouch · 2026 · Journal of Virology
37. Immune memory to COVID-19 vaccines
    Shane Crotty, Alessandro Sette, Daniela Weiskopf · 2023 · ImmPort
38. Maternal immune response and placental antibody transfer by trimester of COVID-19 vaccination
    Andrea G. Edlow, Galit Alter · 2023 · ImmPort